Concord Medical Services Holdings Ltd Receivables Turnover Ratio (CCM), from the fourth quarter 2025 to the fourth quarter 2024 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Concord Medical Services Holdings Ltd  (NYSE: CCM)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Concord Medical Services Holdings Ltd Accounts Receivables Turnover Ratio from the fourth quarter 2025 to the fourth quarter 2024

Quarterly Results, Trends, Rankings, Statistics


Concord Medical Services Holdings Ltd's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the fourth quarter 2025 to a ratio of 3.49, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the fourth quarter 2025. Average receivable collection period, for the Concord Medical Services Holdings Ltd in Dec 31 2025 quarter, has decreased to 105 days, compared to 147 days, in the 0 quarter.

If we take a look into Healthcare sector 549 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2025 from 1814 to 3820.

What is Receivable Turnover Ratio?
What is Concord Medical Services Holdings Ltd Selling?


What is Receivable Turnover Ratio?





CCM Receivables Turnover Ratio (Dec 31 2025)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2024)
IV. Quarter
Y / Y Receivable Change -13.74 % -10.14 % -10.14 % -10.14 % 11.97 %
Y / Y Revenue Change 25.19 % - - - -30.5 %
Receivable Turnover Ratio (TTM) 3.49 2.49 2.47 2.45 2.43
CCM's Total Ranking # 3820 # 1814 # # #
Accounts Receivable average collection period days 105 147 148 149 150
Seq. Receivable Change 798.41 % 0 % 0 % -90.4 % 835.91 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Healthcare Facilities Industry # 46
Healthcare Sector # 550
Overall Market # 3820

Receivable Turnover Ratio Statistics
High Average Low
0.21 0.09 0.04
(Dec 31 2014)   (Dec 31 2018)






Financial Statements
Concord Medical Services Holdings Ltd's Accounts Receivable $ 57 Millions Visit CCM's Balance sheet
Concord Medical Services Holdings Ltd's Sales TTM $ 66 Millions Visit CCM's Income Statement
Sources of CCM's Revenues Visit CCM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CCM's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CCM's Growth Rates CCM's Roa CCM's Inventory Turnover Ratio CCM's Dividend Comparisons
CCM's Profitability Ratios CCM's Roi CCM's Asset Turnover Ratio CCM's Dividend Growth
CCM's Valuation Ratios CCM's Roe CCM's Financial Strength Ratios CCM's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Receivable at quarter ending Dec 31 2025
Phathom Pharmaceuticals Inc   3.16 $ 175.110  Millions$ 55.384  Millions
Keenova Therapeutics Plc  3.15 $ 1,450.500  Millions$ 460.750  Millions
Harrow Inc   3.15 $ 270.837  Millions$ 86.095  Millions
Autolus Therapeutics Plc  3.09 $ 75.388  Millions$ 24.397  Millions
Journey Medical Corp  3.04 $ 61.858  Millions$ 20.359  Millions
Biontech Se  2.99 $ 3,243.679  Millions$ 1,084.641  Millions
Insight Molecular Diagnostics Inc   2.98 $ 4.055  Millions$ 1.360  Millions
Establishment Labs Holdings Inc   2.98 $ 210.308  Millions$ 70.567  Millions
Aclarion Inc   2.98 $ 0.076  Millions$ 0.025  Millions
Adc Therapeutics Sa  2.96 $ 81.357  Millions$ 27.495  Millions
Cormedix Inc   2.86 $ 303.837  Millions$ 106.093  Millions
Celularity Inc   2.83 $ 26.550  Millions$ 9.369  Millions
Cartesian Therapeutics Inc   2.83 $ 2.797  Millions$ 0.989  Millions
Electromed Inc   2.79 $ 68.064  Millions$ 24.380  Millions
American Shared Hospital Services  2.76 $ 28.064  Millions$ 10.160  Millions
Kura Oncology Inc   2.75 $ 67.482  Millions$ 24.515  Millions
Allurion Technologies Inc   2.64 $ 14.571  Millions$ 5.523  Millions
Astrotech Corp  2.61 $ 1.199  Millions$ 0.460  Millions
Docgo Inc   2.57 $ 322.196  Millions$ 125.355  Millions
Regeneron Pharmaceuticals Inc   2.54 $ 14,342.900  Millions$ 5,649.800  Millions
Hyperfine Inc   2.49 $ 12.753  Millions$ 5.132  Millions
Tg Therapeutics Inc   2.48 $ 616.287  Millions$ 248.162  Millions
Profound Medical Corp   2.45 $ 16.098  Millions$ 6.558  Millions
Brightspring Health Services Inc   2.43 $ 2,402.777  Millions$ 987.654  Millions
Fennec Pharmaceuticals Inc   2.36 $ 44.642  Millions$ 18.879  Millions
Burning Rock Biotech Limited  2.36 $ 77.157  Millions$ 32.727  Millions
Sensus Healthcare Inc   2.34 $ 26.867  Millions$ 11.504  Millions
Proqr Therapeutics N v   2.25 $ 17.978  Millions$ 7.980  Millions
Scilex Holding Company  2.22 $ 30.253  Millions$ 13.643  Millions
60 Degrees Pharmaceuticals Inc   2.04 $ 1.006  Millions$ 0.492  Millions

Date modified: 2026-07-07T09:47:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.